Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001618835-19-000214)

Filing Details

Accession Number:: 0001618835-19-000214
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-12-04 17:34:05
Reporting Period:: 2019-12-02

Accepted Time:: 2019-12-04 17:34:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1618835	Evofem Biosciences Inc.	EVFM	Pharmaceutical Preparations (2834)	208527075

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1726183	Kelly Culwell	C/O Evofem Biosciences, Inc. 12400 High Bluff Drive, Suite 600 San Diego CA 92130	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-12-02	1,000	$7.35	43,538	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019.